What Happened?
Ann Arbor, MI-based Esperion Therapeutics Appointed Stanley Jacobs as Director IT
About the Company
Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren`t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion commercializes NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Tablets and is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol.
About the Person
Stanley Jacobs is Director IT at Esperion Therapeutics. Previously, Stanley held various senior IT leadership roles in the industry.
Info Source
News
Short Profile